<?xml version="1.0" encoding="UTF-8"?>
<p>Neuroprotective agents aiming to interrupt 
 <italic>Î±</italic>-synuclein aggregation or to restore neuronal integrity are currently not available, whereas some cognitive interventions that are helpful in Alzheimer's disease have been identified to have positive results in the early stage of randomized clinical studies [
 <xref rid="B112" ref-type="bibr">111</xref>, 
 <xref rid="B113" ref-type="bibr">112</xref>].
</p>
